Drugs / cis-platemum
last change Dec 2025 re-read 2 minutes ago

cis-platemum

Developed for
lung adenocarcinoma
Investigated by
Jun Liu

Trials 1 · a red edge is where a trial was stopped

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT05527808 Aug 2022 → Jun 2025 lung adenocarcinoma Jun Liu Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as cis-platemum ClinicalTrials.gov intervention name — accepted as the source's own label NCT05527808
Route Intravenous “60-75mg/m2 ,intravenous injection ,Q3W 2-4 cycles” NCT05527808